Surendra K. Sharma, Tamilarasu Kadhiravan, Prathap Tharyan
{"title":"Cochrane in context: Rifamycins compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB","authors":"Surendra K. Sharma, Tamilarasu Kadhiravan, Prathap Tharyan","doi":"10.1002/ebch.1959","DOIUrl":null,"url":null,"abstract":"<p><b>Cochrane Review: Rifamycins (rifampicin, rifabutin, and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB</b> Sharma SK, Sharma A, Kadhiravan T, Tharyan P. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD007545. DOI: 10.1002/14651858.CD007545.pub2.</p><p>This companion piece to the review, “Rifamycins (rifampicin, rifabutin, and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB,” contains the following pieces:\n\n </p>","PeriodicalId":12162,"journal":{"name":"Evidence-based child health : a Cochrane review journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2014-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/ebch.1959","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence-based child health : a Cochrane review journal","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ebch.1959","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Cochrane Review: Rifamycins (rifampicin, rifabutin, and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB Sharma SK, Sharma A, Kadhiravan T, Tharyan P. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD007545. DOI: 10.1002/14651858.CD007545.pub2.
This companion piece to the review, “Rifamycins (rifampicin, rifabutin, and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB,” contains the following pieces: